BALCHEM CORP's ticker is BCPC and the CUSIP is 057665200. A total of 145 filers reported holding BALCHEM CORP in Q2 2013. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,297,000 | +274.7% | 23,400 | +212.0% | 0.01% | +233.3% |
| Q1 2018 | $613,000 | -35.1% | 7,500 | -36.0% | 0.00% | -25.0% |
| Q4 2017 | $945,000 | -69.2% | 11,726 | -70.3% | 0.00% | -77.8% |
| Q2 2017 | $3,070,000 | -21.4% | 39,500 | -16.7% | 0.02% | -43.8% |
| Q1 2017 | $3,906,000 | -11.2% | 47,400 | -9.5% | 0.03% | 0.0% |
| Q4 2016 | $4,397,000 | +180.1% | 52,400 | +158.9% | 0.03% | +190.9% |
| Q3 2016 | $1,570,000 | +74.6% | 20,242 | +34.3% | 0.01% | +83.3% |
| Q2 2016 | $899,000 | +159.1% | 15,069 | +164.4% | 0.01% | +200.0% |
| Q3 2015 | $347,000 | -40.9% | 5,700 | -35.2% | 0.00% | -60.0% |
| Q4 2014 | $587,000 | -46.0% | 8,800 | -56.7% | 0.01% | -50.0% |
| Q2 2014 | $1,087,000 | +6.5% | 20,300 | +3.7% | 0.01% | +11.1% |
| Q1 2014 | $1,021,000 | -14.7% | 19,575 | -4.0% | 0.01% | +12.5% |
| Q4 2013 | $1,197,000 | -76.1% | 20,400 | -78.9% | 0.01% | -20.0% |
| Q3 2013 | $5,008,000 | +63.6% | 96,750 | +41.4% | 0.01% | -16.7% |
| Q2 2013 | $3,061,000 | – | 68,407 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SANTA MONICA PARTNERS LP | 425,686 | $49,048,000 | 36.25% |
| Conestoga Capital Advisors, LLC | 939,134 | $108,207,000 | 1.72% |
| Tributary Capital Management, LLC | 197,207 | $22,722,000 | 1.63% |
| Ellsworth Advisors, LLC | 16,335 | $1,882,000 | 1.36% |
| GENEVA CAPITAL MANAGEMENT LLC | 693,677 | $79,926,000 | 1.35% |
| Brown Capital Management | 1,391,418 | $160,319,000 | 1.11% |
| BARD ASSOCIATES INC | 107,550 | $12,390,000 | 0.98% |
| Advantage Alpha Capital Partners LP | 38,370 | $4,421,000 | 0.97% |
| MOODY ALDRICH PARTNERS LLC | 50,270 | $5,792,000 | 0.94% |
| Cutter & CO Brokerage, Inc. | 29,369 | $3,384,000 | 0.89% |